Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many non-cancer medicines have been approved for use by the Innovative Medicines Fund in each year since June 2022.
The following table shows the number of non-cancer medicines that have been approved for use by the Innovative Medicines Fund, broken down by those available via managed access agreements and interim funding agreements:
Year | Managed access | Interim funding |
2022/23 | - | - |
2023/24 | - | 4 |
2024/25 | 3 | 10 |
Source: NHS England.
The National Institute for Health and Care Excellence’s overall approval rate for non-cancer medicines is very high, with 88% of all of medicines it has evaluated recommended for National Health Service funding for some or all of the eligible patient population.